HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 441397Erstellt: 27. Oktober 2026
Bacampicillin
Carampicillin · BACAMPICILLIN · BACAMPICILLIN USP/EP/BP · BACAMPICILLIN HCL USP(CRM STANDARD) · Bacampicillin (base and/or unspecified salts) · 6α-[[(R)-2-Amino-2-phenylacetyl]amino]penicillanic acid 1-[(ethoxycarbonyl)oxy]ethyl ester · (2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 1-(ethoxycarbonyloxy)ethyl ester · 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-, 1-[(ethoxycarbonyl)oxy]ethyl ester, (2S,5R,6R)-
https://huagongshe.com/de/chemical/441397
Identifikatoren & physikalische Daten
| CAS No. | 50972-17-3 |
|---|
| Summenformel | C21H27N3O7S |
|---|
| Durchschnittliche Molmasse | 465,5 g/mol |
|---|
| Monoisotopische Masse | 465,1569712 g/mol |
|---|
| SMILES | CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C |
|---|
| InChIKey | PFOLLRNADZZWEX-FFGRCDKISA-N |
|---|
| PubChem CID | 441397 |
|---|
| ChEMBL | CHEMBL1583 |
|---|
| ChEBI | CHEBI:2968 |
|---|
| DTXSID | DTXSID2048030 |
|---|
Chemische & physikalische Eigenschaften
| XLogP | 2,7 |
|---|
| Polarare Oberfläche (TPSA) | 163 |
|---|
| H-Brücken-Donoren | 2 |
|---|
| H-Brücken-Akzeptoren | 9 |
|---|
| Frei drehbare Bindungen | 10 |
|---|
| Schwere Atome | 32 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 756 |
|---|
| Arzneimittel | Pharmaceuticals -> Antibiotics |
|---|
| Löslichkeit | 1.23e-01 g/LSoluble in DMSO |
|---|
| Human Drugs | Breast FeedingLactationMilk, HumanAnti-Infective AgentsAntibacterial AgentsPenicillins |
|---|
| Schmelzpunkt | 171-176 |
|---|
| Physical Description | Solid |
|---|
| Siedepunkt | 678.4±55.0 °C(Predicted) |
|---|
| Dichte | 1.37±0.1 g/cm3(Predicted) |
|---|
| Lagerbedingungen | Store at -20°C |
|---|
| pKa (Säurekonstante) | pKa 6.8 (Uncertain) |
|---|
| CAS Datenbank | 50972-17-3 |
|---|
Sicherheit & Vorschriften
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)BacampicillinDILI PositiveDOI:10.1016/j.drudis.2019.09.022 |
|---|
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
|---|